{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:07:26Z","timestamp":1790377646794,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1023\/a:1006494032052","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T02:03:28Z","timestamp":1040522608000},"page":"245-249","source":"Crossref","is-referenced-by-count":34,"title":["Second Line Chemotherapy with Docetaxel in Patients with Recurrent Malignant Glioma: A Phase II Study"],"prefix":"10.1007","volume":"50","author":[{"given":"M.","family":"Sanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Keime-Guibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ph","family":"Bro\u00ebt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hoang-Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Y.","family":"Delattre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"310796_CR1","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.1995.13.10.2643","volume":"13","author":"JE Cortes","year":"1995","unstructured":"Cortes JE, Pazdur R: Docetaxel. J Clin Oncol 13: 2643-2655, 1995","journal-title":"J Clin Oncol"},{"issue":"Suppl9","key":"310796_CR2","first-page":"1","volume":"26","author":"HA Burris","year":"1999","unstructured":"Burris HA: Single-agent docetaxel (Taxotere) in randomized phase III trials. Semin Oncol 26(Suppl 9): 1-6, 1999","journal-title":"Semin Oncol"},{"key":"310796_CR3","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1200\/JCO.1995.13.8.2066","volume":"13","author":"MC Chamberlain","year":"1995","unstructured":"Chamberlain MC, Kormanik P: Salvage chemotherapy with paclitaxel for recurrent primary brain tumors. J Clin Oncol 13: 2066-2071, 1995","journal-title":"J Clin Oncol"},{"key":"310796_CR4","first-page":"4845","volume":"51","author":"MC Bissery","year":"1991","unstructured":"Bissery MC, Guenard D, Gueritte-Voegelein F, Lavelle P: Experimental antitumor activity of taxotere (RP 56976,NSC 628503), a taxol analogue. Cancer Res 51: 4845-4852, 1991","journal-title":"Cancer Res"},{"key":"310796_CR5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0006-291X(05)81474-3","volume":"187","author":"JE Riou","year":"1992","unstructured":"Riou JE, Naudin A, Lavelle F: Effects of Taxotere on murine and human tumor cell lines. Biochem Biophys Res Commun 187: 164-170, 1992","journal-title":"Biochem Biophys Res Commun"},{"key":"310796_CR6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR, Cascino TL, Schold SC, Cairncross JG: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277-1280, 1990","journal-title":"J Clin Oncol"},{"key":"310796_CR7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00686276","volume":"33","author":"MA Cahan","year":"1994","unstructured":"Cahan MA, Walter KA, Colvin OM, Brem H: Cytotoxicity of taxol in vitro against human and rat malignant brain tumors. Cancer Chemother Pharmacol 33: 441-444, 1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"310796_CR8","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/jnci\/87.23.1804-a","volume":"87","author":"JJ Heimans","year":"1995","unstructured":"Heimans JJ, Taphoorn MJ, Vermorken JB, Eeltink C, Wolbers JG, Meijer OW, Beijnen JH: Does paclitaxel penetrate into brain tumor tissue? J Natl Cancer Inst 87: 1804-1805, 1995","journal-title":"J Natl Cancer Inst"},{"key":"310796_CR9","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/jnci\/87.14.1077","volume":"87","author":"MJ Glantz","year":"1995","unstructured":"Glantz MJ, Choy H, Kearns CM, Mills PC, Wahlberg LU, Zuhowski EG, Calabresi P, Egorin MJ: Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. J Natl Cancer Inst 87: 1077-1081, 1995","journal-title":"J Natl Cancer Inst"},{"key":"310796_CR10","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1200\/JCO.1997.15.12.3427","volume":"15","author":"MC Chamberlain","year":"1997","unstructured":"Chamberlain MC, Kormanik PA: Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas. J Clin Oncol 15: 3427-3432, 1997","journal-title":"J Clin Oncol"},{"key":"310796_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1006277631745","volume":"43","author":"MC Chamberlain","year":"1999","unstructured":"Chamberlain MC, Kormanik P: Salvage chemotherapy with taxol for recurrent anaplastic astrocytomas. J Neuro-Oncol 43: 71-78, 1999","journal-title":"J Neuro-Oncol"},{"key":"310796_CR12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00210791","volume":"14","author":"P Forsyth","year":"1996","unstructured":"Forsyth P, Cairncross G, Stewart D, Goodyear M, Wainman N, Eisenhauer E: Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group. Invest New Drugs 14: 203-206, 1996","journal-title":"Invest New Drugs"},{"key":"310796_CR13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jnci\/83.4.288","volume":"83","author":"I Ringer","year":"1991","unstructured":"Ringer I, Horwitz S: Studies with RP56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 83: 288-291, 1991","journal-title":"J Natl Cancer Inst"},{"key":"310796_CR14","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1200\/JCO.1998.16.6.2188","volume":"16","author":"SM Chang","year":"1998","unstructured":"Chang SM, Kuhn JG, Rizzo J, Robins HI, Schold SC, Spence AM, Berger MS, Mehta MP, Bozik ME, Pollack I, Gilbert M, Fulton D, Rankin C, Malec M, Prados MD: Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium Report. J Clin Oncol 16: 2188-2194, 1998","journal-title":"J Clin Oncol"},{"key":"310796_CR15","first-page":"2207","volume":"54","author":"KA Walter","year":"1994","unstructured":"Walter KA, Cahan MA, Gur A, Tyler B, Hilton J, Colvin OM, Burger PC, Domb A, Brem H: Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res 54: 2207-2212, 1994","journal-title":"Cancer Res"},{"key":"310796_CR16","first-page":"12","volume":"9","author":"L Milas","year":"1999","unstructured":"Milas L, Milas MM, Mason KA: Combination of taxanes with radiation: preclinical studies. Sem Oncol 9: 12-26, 1999","journal-title":"Sem Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006494032052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006494032052\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006494032052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:07:21Z","timestamp":1749632841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006494032052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["310796"],"URL":"https:\/\/doi.org\/10.1023\/a:1006494032052","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}